We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
23andMe Holding Company | NASDAQ:ME | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0016 | -0.32% | 0.496 | 0.4855 | 0.4978 | 0.515 | 0.475 | 0.4868 | 2,102,554 | 23:00:02 |
ARRAY, the multi-platform arts and social impact collective founded by Ava DuVernay, created the Seat16 initiative to ensure that 10,000 young people across the nation get to experience ORIGIN.
Written, directed, and produced by Academy Award nominee Ava DuVernay, ORIGIN explores the mystery of history, the wonders of romance, and a fight for our future. While investigating the global phenomenon of caste and its dark influence on society, a journalist faces unfathomable personal loss and uncovers the beauty of human resilience. With an expansive cast that includes Academy Award nominee Aunjanue Ellis-Taylor, Jon Bernthal, and Niecy Nash-Betts, the film was inspired by Pulitzer Prize-winning journalist Isabel Wilkerson's novel Caste: The Origin of Our Discontents.
“It’s a scientific fact we are all 99.5 percent genetically identical. We are more alike than we are different and sometimes people forget humans have created hierarchies and caste systems. As a brand we focus on the knowledge that we are all connected, equally, through our DNA,” said Tracy Keim, Chief Brand Officer at 23andMe. “Supporting Ava DuVernay, ARRAY and the ORIGIN team by purchasing tickets for young adults through their Seat 16 program, encourages a new generation to have the opportunity to be educated through the film’s storytelling about our connection, not our differences.”
View the film's trailer here. Through her foundation, 23andMe co-founder and CEO Anne Wojcicki helped fund the film along with several other non-profits.
About 23andMe23andMe is a genetics-led consumer healthcare and biopharmaceutical company empowering a healthier future. For more information, please visit www.23andMe.com.
ContactsMedia Contact: press@23andMe.com
1 Year 23andMe Chart |
1 Month 23andMe Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions